Dr. Adam Daniel Cash, MD

Dr. Cash practices at Mercy Health - St. Elizabeth Youngstown Hospital in Youngstown, Ohio, part of Bon Secours Mercy Health.

Dr. Cash's NPI, 1003016205, was assigned on July 25, 2007. Dr. Cash graduated from Cleveland Medical College, Homeopathic in 2006. Dr. Cash holds Ohio license 35.0993394.

Dr. Cash's primary practice is Mercy Health - St. Elizabeth Youngstown Hospital, at 1044 Belmont Avenue, Youngstown, OH 44501 in Mahoning County. The practice phone is (330) 480-3022.

Dr. Cash's primary practice is Mercy Health - St. Elizabeth Youngstown Hospital in Youngstown, Ohio, part of Bon Secours Mercy Health. Dr. Cash is also affiliated with Mercy Health - St. Joseph Warren Hospital. The medical group on file is Mercy Health Physicians. Dmand AI also links Dr. Cash to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cash practices, 4 sites in all. Vendor and product names are available with a free account.

Plastic surgery is Dr. Cash's primary specialty in the NPI Registry, under taxonomy code 208200000X. Dr. Cash is board certified in plastic surgery by the American Board of Plastic Surgery. Dr. Cash is licensed in Ohio.

Dmand AI lists breast surgery and cancerous skin growth removal among the conditions Dr. Cash treats.

CMS data shows 167 Medicare services from Dr. Cash across 7 procedure codes in 2024, for 146 Medicare patients. Medicare paid $15,926 for them.

CMS counts 146 Medicare patients who saw Dr. Cash in 2024. The largest group is 65 to 74, with 69 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Cash's median patient age at 54, with 73% women.

In 2024, Dr. Cash wrote 20 Medicare Part D claims for 12 patients. 65% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $9,399 in total drug cost. In 2021, CMS named 11 claims across 1 drug.

Dr. Cash accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 27 procedures of melanoma (skin cancer) excision by Dr. Cash, more than 79% of the clinicians it reports for that procedure.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 14 papers to Dr. Cash, published from 2004 to 2021. The most frequent topics are Alzheimer Disease, Oxidative Stress and Copper. Dr. Cash's most frequent co-authors are Brandon Eugene Fornwalt, Ryan David Konik, MD and Catherine Anne Rottkamp, MD.

Dmand AI links Dr. Cash to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain.

CMS Open Payments shows 155 general payments to Dr. Cash from 27 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 39% of the total. Smith & Nephew, Inc. paid the most, $12,583.

Dmand AI lists 1 award for Dr. Cash, most recently CMS Stage 1 EHR in 2013.

Dr. Cash graduated from Cleveland Medical College, Homeopathic in 2006.

Dr. Cash is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.